ATLAS / Macro Radar / Reporting / AKBA

Akebia Therapeutics, Inc. (AKBA) reporting calendar

Akebia Therapeutics, Inc. files periodic reports with the SEC as AKBA on Nasdaq. Atlas tracks 49 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
21 Jul 2026 – 24 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
49

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 38 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open AKBA market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001517022-26-000039
10-K31 Dec 202526 Feb 202657 days0001517022-26-000020
10-Q30 Sep 202510 Nov 202541 days0001517022-25-000046
10-Q30 Jun 20257 Aug 202538 days0001628280-25-038600
10-Q31 Mar 20258 May 202538 days0001628280-25-023460
10-K31 Dec 202413 Mar 202572 days0001628280-25-012470
10-Q30 Sep 20247 Nov 202438 days0001628280-24-045979
10-Q30 Jun 20248 Aug 202439 days0001628280-24-035879
10-Q31 Mar 20249 May 202439 days0001628280-24-021945
10-K31 Dec 202314 Mar 202474 days0001628280-24-011270
10-Q30 Sep 20238 Nov 202339 days0001628280-23-037557
10-Q30 Jun 202328 Aug 202359 days0001628280-23-030698
10-Q31 Mar 20238 May 202338 days0001628280-23-016258
10-K31 Dec 202210 Mar 202369 days0001628280-23-007539
10-Q30 Sep 20223 Nov 202234 days0001628280-22-028242
10-Q30 Jun 20224 Aug 202235 days0001628280-22-021096
10-Q31 Mar 20229 May 202239 days0001628280-22-013318
10-K31 Dec 20211 Mar 202260 days0001628280-22-004522
10-Q30 Sep 20214 Nov 202135 days0001628280-21-021760
10-Q30 Jun 20215 Aug 202136 days0001628280-21-015865
10-Q31 Mar 202110 May 202140 days0001628280-21-009696
10-K31 Dec 202025 Feb 202156 days0001628280-21-003283
10-Q30 Sep 20205 Nov 202036 days0001628280-20-015733
10-Q30 Jun 202010 Aug 202041 days0001628280-20-012337
10-Q31 Mar 20205 May 202035 days0001564590-20-021255
10-K31 Dec 201912 Mar 202072 days0001564590-20-010491
10-Q30 Sep 201912 Nov 201943 days0001564590-19-042962
10-Q30 Jun 20198 Aug 201939 days0001564590-19-030771
10-Q31 Mar 20199 May 201939 days0001564590-19-017969
10-K31 Dec 201826 Mar 201985 days0001564590-19-009340
10-Q30 Sep 20188 Nov 201839 days0001564590-18-028587
10-Q30 Jun 20188 Aug 201839 days0001564590-18-020459
10-Q31 Mar 20189 May 201839 days0001564590-18-012395
10-K31 Dec 201712 Mar 201871 days0001564590-18-005286
10-Q30 Sep 20178 Nov 201739 days0001564590-17-022727
10-Q30 Jun 20178 Aug 201739 days0001564590-17-016542
10-Q31 Mar 20179 May 201739 days0001564590-17-009841
10-K31 Dec 20166 Mar 201765 days0001564590-17-003466
10-Q30 Sep 20169 Nov 201640 days0001564590-16-028609
10-Q30 Jun 20168 Aug 201639 days0001564590-16-023285

Source: SEC EDGAR company submissions for CIK 0001517022. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.